People moves: Biopharma finance & accounting
George Eldridge was appointed chief financial officer of Abcuro, a clinical-stage biotech developing therapies for the treatment of autoimmune diseases...
George Eldridge was appointed chief financial officer of Abcuro, a clinical-stage biotech developing therapies for the treatment of autoimmune diseases...
Parliament on Wednesday, voted unanimously, 200-0, to adopt measures to prevent and ban the marketing, supply and sale of products...